Internships at Indero

About Indero

Indero takes a holistic approach to clinical research, merging expertise in dermatology and rheumatology to deliver innovative solutions for immune-mediated inflammatory diseases. Our dedicated team tackles the complexities of trials with a patient-centered focus, turning challenges into opportunities. Indero is one of three brands (Indero, Innovaderm, and Clinago) working together to advance dermatology and rheumatology research. Each pillar contributes in its own unique way to drive progress in immune-mediated inflammatory diseases. Innovaderm is our dedicated clinical research site for high-quality, hands-on studies. Equipped with the infrastructure and resources essential for dermatology trials, this unit sets the foundation for precise, impactful research. As a dual-focus CRO, Indero brings decades of expertise to each clinical trial phase. Specializing in dermatology and rheumatology, our team ensures trials are conducted to the highest standards, meeting the demands of immune-mediated inflammatory disease studies. Clinago , our proprietary patient recruitment platform, provides reliable, accelerated participant enrollment for dermatology and rheumatology studies. Leveraging an expansive patient network, Clinago shortens recruitment timelines, helping clients achieve their study goals. Strengthened CRO activities aimed at multicenter studies, enhancing operational efficiency and research outcomes. At Indero, we are dedicated to philanthropy to improve patients’ health and quality of life. In the past 5 years, Indero and parent companies have donated several million dollars to research institutes and universities for the advancement of academic medical research. Our commitment to innovation and patient care makes Indero a place where meaningful impacts are made every day. Impactful science requires expertise, passion, and a relentless pursuit of excellence. Together, we tackle the complexities of clinical trials, ensuring every study achieves the best possible outcomes. If you’re ready to contribute to meaningful advancements in clinical research, we want you on our team. Ready to take the next step in dermatology and rheumatology research? Let’s transform the future of immune-mediated inflammatory disease treatment together. Jeff Smith, CEO of Indero, brings nearly 30 years of experience in the pharmaceutical and CRO industry, having distinguished himself through exceptional leadership, strategic vision, and innovation. Jeff’s expertise spans global operations, growth management, and fostering a collaborative corporate culture. His strengths in val

More from Indero